These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6368886)

  • 1. Landmark perspective: Nitrogen mustard therapy.
    Freireich E
    JAMA; 1984 May; 251(17):2262-3. PubMed ID: 6368886
    [No Abstract]   [Full Text] [Related]  

  • 2. Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. By Louis S. Goodman, Maxwell M. Wintrobe, William Dameshek, Morton J. Goodman, Alfred Gilman and Margaret T. McLennan.
    Goodman LS; Wintrobe MM; Dameshek W; Goodman MJ; Gilman A; McLennan MT
    JAMA; 1984 May; 251(17):2255-61. PubMed ID: 6368885
    [No Abstract]   [Full Text] [Related]  

  • 3. [Developmental history: bendamustine yesterday, today, tomorrow].
    Werner W; Herold M; Ruffert K; Merkle K; Brakhage A; Leoni L; Cheson BD
    Onkologie; 2013; 36 Suppl 1():2-10. PubMed ID: 23445757
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pioneer use of nitrogen mustard by Emilio Roda Pérez in the treatment of idiopathic uveitis].
    Bergua A
    Arch Soc Esp Oftalmol; 2006 Sep; 81(9):557-62. PubMed ID: 17016790
    [No Abstract]   [Full Text] [Related]  

  • 5. From wild fowl to stalking horses: alchemy in chemotherapy. Fifth annual David A. Karnofsky Memorial Lecture.
    Burchenal JH
    Cancer; 1975 Apr; 35(4):1121-35. PubMed ID: 163674
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer chemotherapy: What drugs are available.
    Carter SK; Kershner LM
    Med Times; 1976 Feb; 104(2):154-62. PubMed ID: 1246181
    [No Abstract]   [Full Text] [Related]  

  • 7. Hodgkin's disease.
    Galton DA
    Br Med J; 1979 Sep; 2(6190):587-9. PubMed ID: 91404
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Adverse reaction to nitrogen mustard therapy.
    Carpentieri U; Gustavson LP; Lockhart LH; Haggard ME
    J Pediatr; 1976 Jun; 88(6):1064. PubMed ID: 1271180
    [No Abstract]   [Full Text] [Related]  

  • 9. Classics in oncology. The sword and the ploughshare; Cornelius P. Rhoads. Excerpted from the Journal of the Mount Sinai Hospital, Volume XIII, Number 6, 1946.
    Rhoads CP
    CA Cancer J Clin; 1978; 28(5):306-12. PubMed ID: 100191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of Peptichemio in some hemoblastoses and solid tumors].
    Pacilio G; Annunziato L; Lobefalo G
    G Ital Chemioter; 1974; 21(1):22-7. PubMed ID: 4619383
    [No Abstract]   [Full Text] [Related]  

  • 11. Compound X given intravenously. On the history of the nitrogen mustards.
    Dauber LG
    N Y State J Med; 1984 Mar; 84(3 Pt 1):122-4. PubMed ID: 6371609
    [No Abstract]   [Full Text] [Related]  

  • 12. Cornelius Packard Rhoads 1898--1959.
    CA Cancer J Clin; 1978; 28(5):304-12. PubMed ID: 100190
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of dopan therapy of lymphogranulomatosis based on the data of the Khirgizin Scientific Research Institute of Oncology and Radiology].
    Sikorskaia IaV
    Sov Zdravookhr Kirg; 1965; 2():34-8. PubMed ID: 4221039
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of a new nitrogen-mustard compound.
    SELLEI C; ECKHARDT S; HARTAI F; DUMBOVICH B
    Lancet; 1956 May; 270(6926):785-6. PubMed ID: 13320884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
    INGRASSIA G; VASILE B
    Haematologica; 1951; 35(10):907-53. PubMed ID: 14906882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with N-Lost phosphamide esters].
    Drings P; Allner R; Brock N; Burkert H; Fischer M; Fölsch E; Gerhartz H; Götzky P; Hoppe I; Kanzler G; Klein HO; Mainzer K; Martin H; Obrecht P; Palme G; Paulisch H; Riegg H; Schubert JC; Treske U; Weise W; Willems D; Wilmanns H; Witte S; Wohlenberg H
    Dtsch Med Wochenschr; 1970 Mar; 95(10):491-7. PubMed ID: 4905291
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma.
    D'Elia GM; De Angelis F; Breccia M; Annechini G; Panfilio S; Danieli R; Cavalieri E; Pulsoni A
    Leuk Res; 2010 Nov; 34(11):e300-1. PubMed ID: 20630589
    [No Abstract]   [Full Text] [Related]  

  • 18. Bendamustine: a bridge to longer term solutions in heavily treated Hodgkin lymphoma.
    Moskowitz A
    Leuk Lymphoma; 2013 Nov; 54(11):2339-40. PubMed ID: 24093891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined chemotherapy with asaline and cyclophosphane under experimental and clinical conditions].
    Vershinina SF; Gershanovich ML; Chekharina EA
    Vopr Onkol; 1969; 15(11):48-53. PubMed ID: 4904839
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polychemotherapy in generalized form of Hodgkin's disease].
    van Hove W; Hamers J; Baele G; Vermeulen A
    Acta Clin Belg; 1975; 30(4):277-82. PubMed ID: 1211048
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.